Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 532039 | NSE Symbol : | ISIN : INE486F01012 | Industry : Pharmaceuticals - Indian - Formulations |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
21-Apr-2025	25-Apr-2025	Accounts	Zenotech Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2025 inter alia to consider and approve Audited Standalone Financial Results for the quarter and financial year ended March 31 2025. Pursuant to Regulation 33 & 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we enclose herewith the following: 1. the Standalone Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 together with the Report of Auditors'' on the said Results, duly approved and taken on record by the Board of Directors of the Company at their meeting held today, i.e., April 25, 2025; and 2. Declaration under Regulation 33(3)(d) of SEBI LODR Submission of Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 (As per BSE Announcement Dated on 25/04/2025)
18-Jan-2025	28-Jan-2025	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 inter alia to consider and approve unaudited standalone financial results for the quarter and nine months ended December 31 2024. Unaudited Financial Results for the quarter and nine months ended December 31, 2024 (As Per BSE Announcement dated on 28.01.2025)
17-Oct-2024	23-Oct-2024	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve the Unaudited Standalone Financial Results for the quarter and half year ended September 30 2024 Unaudited Financial Results for the quarter and half year ended September 30, 2024 and appointment of Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) of the Company with immediate effect. (As Per BSE Announcement dated on 23.10.2024)
18-Jul-2024	26-Jul-2024	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve Quarterly Standalone Financial Results for Q1 of FY 2024-25. As per letter attached (As per BSE Announcement Dated on 26/07/2024)
24-Apr-2024	01-May-2024	Accounts	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/05/2024 inter alia to consider and approve Audited Standalone Financial Results of the Company for the fourth quarter and Financial Year ended March 31 2024 Audited Standalone Financial Results of the Company for the fourth quarter and financial year ended March 31, 2024 together with the Report of Auditors'' on the financial results. (As Per BSE Announcement dated on 01.05.2024)
17-Jan-2024	29-Jan-2024	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2024 inter alia to consider and approve Unaudited Financial Results for the quarter and nine months ended December 31 2023. Unaudited Financial Results for the quarter and nine months ended December 31, 2023 along with Limited Review Report thereon issued by the Statutory Auditors of the Company. With reference to the intimation of Board Meeting submitted on January 17, 2024, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. January 29, 2024 which commenced at 5:00 p.m. IST and ended at 6:15 p.m. IST. The Board has, inter-alia, approved and taken on record the Unaudited Standalone Financial Results for the quarter and nine months ended December 31, 2023. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2023 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. (As per BSE Announcement Dated on 29/01/2024)
19-Oct-2023	30-Oct-2023	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2023 inter alia to consider and approve unaudited financial results for the quarter and half year ended September 30 2023. Unaudited Financial Results for the quarter and half year ended September 30, 2023 (As Per BSE Announcement Dated on 30/10/2023)
25-Jul-2023	01-Aug-2023	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2023 inter alia to consider and approve Unaudited Standalone Financial Results of the Company for the quarter ended June 30 2023. ZENOTECH LABORATORIES LIMITED has informed BSE about Board Meeting to be held on 01 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. With reference to the intimation of Board Meeting submitted on July 25, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. August 01, 2023, which commenced at 5:45 pm and ended at 7:30 pm IST. The Board of Directors has, inter-alia, approved Unaudited Financial Results of the Company for the quarter ended June 30, 2023. Pursuant to Regulation 30 and 33 of SEBI LODR Regulations, we enclose herewith the Unaudited Financial Results of the Company for the quarter ended June 30, 2023along with the Limited Review Report of the Statutory Auditors. (As Per BSE Announcement dated on 01.08.2023)
21-Apr-2023	28-Apr-2023	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2023 inter alia to consider and approve Audited Standalone Financial Results of the Company for the fourth quarter and financial year ended March 31 2023 Audited Results (As Per BSE Bulletin dated on 21.04.2023) Pursuant to the Regulation 33 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board of Directors of the Company at its meeting held today, i.e. April 28, 2023, have considered and approved the Audited Standalone Financial Results of the Company for the quarter and financial year ended on March 31, 2023 along with the Report of Auditors thereon, and A Declaration (Unmodified opinion) under Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is also enclosed. The meeting of the Board of Directors commenced at 5:30 PM and concluded at 7:50 PM. The aforesaid information is also being uploaded on the Company's website at www.zenotechlab.com. (As Per BSE Announcement Dated on 28.04.2023)
19-Jan-2023	27-Jan-2023	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2023 inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31 2022. With reference to the intimation of Board Meeting submitted on January 19, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. January 27, 2023 which commenced at 5:30 p.m. IST and ended at 7:15 p.m. IST. The Board has, inter-alia, approved Unaudited Standalone Financial Results for the quarter and nine months ended December 31, 2022. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. With reference to the intimation of Board Meeting submitted on January 19, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. January 27, 2023 which commenced at 5:30 p.m. IST and ended at 7: 15 p.m. IST. The Board has, inter-alia, approved Unaudited Standalone Financial Results for the quarter and nine months ended December 31, 2022. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2022 along with the Limited Review Report thereon issued by the Statutory Auditors of the Company. (As Per BSE Announcement Dated on 27.01.2023)
20-Oct-2022	28-Oct-2022	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30 2022. With reference to the intimation of Board Meeting submitted on October 20, 2022, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. October 28, 2022 which commenced at 5:00 p.m. IST and ended at 7:00 p.m. IST. The Board has, inter-alia, approved Unaudited Standalone Financial Results for the quarter and half year ended September 30, 2022. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2022 along with the Limited Review Report of the Statutory Auditors. (As Per BSE Announcement Dated on 28.10.2022)
14-Jul-2022	22-Jul-2022	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2022 inter alia to consider and approve inter-alia the Unaudited Standalone Financial Results of the Company for the quarter ended June 30 2022 The Board of Directors of the Company at its meeting held today i.e. Friday, July 22, 2022 has inter alia considered and approved the Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2022. Pursuant to the provisions of Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following as 'Annexure': a) Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2022. b) Limited Review Report of the Statutory Auditors of the Company on Unaudited Standalone Financial Results for the quarter ended June 30, 2022. The meeting of the Board of Directors of the Company commenced at 5:00 p.m. and concluded at 6:30 p.m. The Board of Directors of the Company at its meeting held today i.e. Friday, July 22, 2022 has inter alia considered and approved the Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2022. Pursuant to the provisions of Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the following as 'Annexure': a) Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2022. b) Limited Review Report of the Statutory Auditors of the Company on Unaudited Standalone Financial Results for the quarter ended June 30, 2022. The meeting of the Board of Directors of the Company commenced at 5:00 p.m. and concluded at 6:30 p.m. (As Per BSE Announcement Dated on 22.07.2022)
22-Apr-2022	29-Apr-2022	Quarterly Results	Audited Results ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2022 ,inter alia, to consider and approve the Audited Standalone Financial Results of Zenotech Laboratories Limited (the Company) for the fourth quarter and year ended on March 31, 2022 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we enclose herewith the following: 1) the Standalone Audited Financial Results of the Company for the fourth quarter and financial year ended March 31, 2022 together with the Report of Auditors' on the said Results, duly approved and taken on record by the Board of Directors of the Company at their meeting held today, i.e., April 29, 2022; and 2) Declaration under Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting of the Board of Directors commenced at 5:50 PM and concluded at 8:30 PM. We would like to inform that Board of Directors of Zenotech Laboratories Limited (the Company) in their meeting held today i.e. on April 29, 2022 have considered and approved the request received from Daiichi Sankyo Company Limited (Daiichi) for reclassification from 'Promoter' to 'Public' Category'. Please note that currently, Daiichi does not hold any shares in the Company and the reclassification will not impact the overall promoter holding in the Company. The Company shall seek shareholders' approval for the reclassification in line with the provisions of Regulation 31A of SEBI Listing Regulations. As required under SEBI Listing Regulations, we also enclosed herewith as an Annexure - Extract of the minutes of Board Meeting, for your perusal. Request you to kindly take the same on record and oblige. (As Per BSE Announcement dated on 29.04.2022)
18-Jan-2022	28-Jan-2022	Quarterly Results	ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31 2021. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Friday, January 28, 2022, have approved and took on record the limited review Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2021, which are enclosed herewith along with the Limited Review Report of the Statutory Auditors of the Company on Standalone Unaudited Financial Results. The meeting of the Board of Directors of the Company commenced at 5:00 p.m. and concluded at 6:30 p.m. We request you to take the above on record. (As Per BSE Announcement Dated on 28.01.2022)
14-Oct-2021	22-Oct-2021	Quarterly Results	Quarterly Results ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2021 ,inter alia, to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2021 Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Friday, October 22, 2021, have approved and took on record the limited review Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2021, which are enclosed herewith along with the Limited Review Report of the Statutory Auditors of the Company on Standalone Unaudited Financial Results. The meeting of the Board of Directors of the Company commenced at 4:00 p.m. and concluded at 6:30 p.m. We request you to take the above on record. (As Per BSE Announcement dated on 22.10.2021)

1 2

LOGIN HERE

Zenotech Laboratories Ltd

Board Meeting